122 related articles for article (PubMed ID: 3158552)
1. Spironolactone in combination drug therapy for unresponsive hirsutism.
Pittaway DE; Maxson WS; Wentz AC
Fertil Steril; 1985 Jun; 43(6):878-82. PubMed ID: 3158552
[TBL] [Abstract][Full Text] [Related]
2. Treatment of hirsutism related to micropolycystic ovary syndrome (MPCO) with two low-dose oestrogen oral contraceptives: a comparative randomized evaluation.
Sobbrio GA; Granata A; D'Arrigo F; Arena D; Panacea A; Trimarchi F; Granese D; Pullè C
Acta Eur Fertil; 1990; 21(3):139-41. PubMed ID: 2149912
[TBL] [Abstract][Full Text] [Related]
3. Predictors of clinical response in hirsute women treated with spironolactone.
Crosby PD; Rittmaster RS
Fertil Steril; 1991 Jun; 55(6):1076-81. PubMed ID: 1828043
[TBL] [Abstract][Full Text] [Related]
4. Spironolactone in the treatment of hirsutism.
Anttila L; Ruutiainen K; Erkkola R
Ann Chir Gynaecol Suppl; 1987; 202():32-4. PubMed ID: 3310825
[TBL] [Abstract][Full Text] [Related]
5. Comparison of spironolactone and spironolactone plus metformin in the treatment of polycystic ovary syndrome.
Diri H; Karaburgu S; Acmaz B; Unluhizarci K; Tanriverdi F; Karaca Z; Kelestimur F
Gynecol Endocrinol; 2016; 32(1):42-5. PubMed ID: 26370923
[TBL] [Abstract][Full Text] [Related]
6. The effects of spironolactone on testosterone fractions and sex-hormone binding globulin binding capacity in hirsute women.
Marcondes JA; Minanni SL; Luthold WW; Lerário AC; Nery M; Mendonça BB; Wajchenberg BL; Kirschner MA
J Endocrinol Invest; 1995 Jun; 18(6):431-5. PubMed ID: 7594237
[TBL] [Abstract][Full Text] [Related]
7. Long-Term Response of Hirsutism and Other Hyperandrogenic Symptoms to Combination Therapy in Polycystic Ovary Syndrome.
Ezeh U; Huang A; Landay M; Azziz R
J Womens Health (Larchmt); 2018 Jul; 27(7):892-902. PubMed ID: 29878857
[TBL] [Abstract][Full Text] [Related]
8. Peripheral androgen blockade versus glandular androgen suppression in the treatment of hirsutism.
Carmina E; Lobo RA
Obstet Gynecol; 1991 Nov; 78(5 Pt 1):845-9. PubMed ID: 1833685
[TBL] [Abstract][Full Text] [Related]
9. Treatment of hirsutism in women with flutamide.
Marcondes JA; Minnani SL; Luthold WW; Wajchenberg BL; Samojlik E; Kirschner MA
Fertil Steril; 1992 Mar; 57(3):543-7. PubMed ID: 1531466
[TBL] [Abstract][Full Text] [Related]
10. Hirsutism--a low dose spironolactone therapy.
Vĕtr M
Acta Univ Palacki Olomuc Fac Med; 1989; 122():239-45. PubMed ID: 2530821
[TBL] [Abstract][Full Text] [Related]
11. [Significance of sex hormone binding globulin and free androgen index in the estimation of androgenic cases].
Qiao FY; Lauritzen C
J Tongji Med Univ; 1990; 10(2):124-8. PubMed ID: 2145442
[TBL] [Abstract][Full Text] [Related]
12. High serum prostate-specific antigen concentrations in hirsute women do not decrease with treatment by the combination of spironolactone and the contraceptive pill.
Guzelmeric K; Seker N; Unal O; Turan C
Gynecol Endocrinol; 2004 Oct; 19(4):190-5. PubMed ID: 15724801
[TBL] [Abstract][Full Text] [Related]
13. A comparison between spironolactone and spironolactone plus finasteride in the treatment of hirsutism.
Keleştimur F; Everest H; Unlühizarci K; Bayram F; Sahin Y
Eur J Endocrinol; 2004 Mar; 150(3):351-4. PubMed ID: 15012621
[TBL] [Abstract][Full Text] [Related]
14. Use of spironolactone in treatment of hirsutism.
Cumming DC
Cleve Clin J Med; 1990 May; 57(3):285-7. PubMed ID: 2357784
[TBL] [Abstract][Full Text] [Related]
15. Effect of leuprolide and dexamethasone on hair growth and hormone levels in hirsute women: the relative importance of the ovary and the adrenal in the pathogenesis of hirsutism.
Rittmaster RS; Thompson DL
J Clin Endocrinol Metab; 1990 Apr; 70(4):1096-102. PubMed ID: 2156885
[TBL] [Abstract][Full Text] [Related]
16. Comparison of sequential cyproterone acetate/estrogen versus spironolactone/oral contraceptive in the treatment of hirsutism.
O'Brien RC; Cooper ME; Murray RM; Seeman E; Thomas AK; Jerums G
J Clin Endocrinol Metab; 1991 May; 72(5):1008-13. PubMed ID: 1827125
[TBL] [Abstract][Full Text] [Related]
17. The endocrine effects of spironolactone used as an antiandrogen.
Young RL; Goldzieher JW; Elkind-Hirsch K
Fertil Steril; 1987 Aug; 48(2):223-8. PubMed ID: 2956130
[TBL] [Abstract][Full Text] [Related]
18. Short-term treatment of hirsutism related to micropolycystic ovary syndrome with a combination type oral contraceptive containing desogestrel.
Sobbrio GA; Granata A; D'Arrigo F; Arena D; Trimarchi F; Granese D; Pullè C
Acta Eur Fertil; 1989; 20(1):35-7. PubMed ID: 2528880
[TBL] [Abstract][Full Text] [Related]
19. Treatment of hirsutism with spironolactone.
Tremblay RR
Clin Endocrinol Metab; 1986 May; 15(2):363-71. PubMed ID: 2941190
[TBL] [Abstract][Full Text] [Related]
20. 17-Hydroxysteroid dehydrogenase type 5 gene polymorphism (-71A/G HSD17B5 SNP) and treatment with oral contraceptive pills in PCOS women without metabolic comorbidities.
Maier PS; Mattiello SS; Lages L; Spritzer PM
Gynecol Endocrinol; 2012 Aug; 28(8):606-10. PubMed ID: 22329763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]